Guanine

Guanine

SCHEMBL2128709

Cc1c[nH]c(=O)[nH]c1=O.Nc1nc2nc[nH]c2c(=O)[nH]1.Nc1nc2nc[nH]c2c(=O)[nH]1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PNP P00491 3/20 0.70
ATAD2 Q6PL18 1/20 0.51
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
HPGD P15428 1/20 0.46
KMT2A Q03164 1/20 0.46
HSD17B10 Q99714 1/20 0.46
GDA Q9Y2T3 1/20 0.43
GRIA1 P42261 1/20 0.41
GRIA2 P42262 1/20 0.41
GRIA3 P42263 1/20 0.41
GRIA4 P48058 1/20 0.41
XDH P47989 2/20 0.40
CYP1A2 P05177 1/20 0.40
FGFR1 P11362 1/20 0.40
FGFR2 P21802 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanine SCHEMBL6515057 1.00 PNP (0.70) PNPATAD2ALDH1A1KDM4EMEN1
Guanine SCHEMBL1375444 1.00 PNP (0.70) PNPATAD2ALDH1A1KDM4EMEN1
Guanine SCHEMBL29171220 1.00 PNP (0.70) PNPATAD2ALDH1A1KDM4EMEN1
Guanine SCHEMBL6130674 0.91 PNP (0.58) PNPATAD2ALDH1A1KDM4EMEN1
Guanine SCHEMBL4348108 0.91 PNP (0.58) PNPATAD2ALDH1A1KDM4EMEN1
Guanine SCHEMBL23880590 0.89 PNP (0.55) PNPATAD2ALDH1A1KDM4EMEN1
Guanine SCHEMBL17597606 0.89 PNP (0.55) PNPATAD2ALDH1A1KDM4EMEN1
Guanine SCHEMBL2526275 0.89 PNP (0.55) PNPATAD2ALDH1A1KDM4EMEN1
Guanine SCHEMBL20518478 0.89 PNP (0.55) PNPATAD2ALDH1A1KDM4EMEN1
Hypoxanthine SCHEMBL3348064 0.84 ATAD2 (0.63) PNPATAD2ALDH1A1GDAGRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1898803-B1 MOLECULAR/GENETIC ABERRATIONS IN SURGICAL MARGINS OF RESECTED PANCREATIC CANCER REPRESENTS NEOPLASTIC DISEASE THAT CORRELATES WITH DISEASE OUTCOME WAYNE JOHN CANCER INST (US) 2012-04-25 EP disclosed
US-20070031867-A1 Molecular/genetic aberrations in surgical margins of resected pancreatic cancer represents neoplastic disease that correlates with disease outcome JOHN WAYNE CANCER INSTITUTE 2007-02-08 US disclosed